Vinorelbine

FDA Approved: * August 31, 2012
Pharm Company: * ONCO THERAPIES LTD
Category: Cancer

Vinorelbine (NVB), sold under the brand name Navelbine among others, is a chemotherapy medication used to treat a number of types of cancer.[3] This includes breast cancer and non-small cell lung cancer.[3] It is given by injection into a vein or by mouth.[3][1] Common side effects include bone marrow suppression, pain at the site of injection, vomiting, feeling tired, numbness, and diarrhea.[3] Other serious side... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Vinorelbine Tartrate 10 mg/ml Intravenous Injection, Solution
NDC: 0008-0045
Labeler:
Wyeth Pharmaceuticals Company
Vinorelbine 10 mg/ml Intravenous Injection, Solution
NDC: 0069-0099
Labeler:
Pfizer Laboratories Div Pfizer Inc.
Vinorelbine 10 mg/ml Intravenous Injection, Solution
NDC: 0069-0103
Labeler:
Pfizer Laboratories Div Pfizer Inc.
Vinorelbine 10 mg/ml Intravenous Injection, Solution
NDC: 0069-0205
Labeler:
Pfizer Laboratories Div Pfizer Inc.
Vinorelbine 10 mg/ml Intravenous Injection
NDC: 0703-4182
Labeler:
Teva Parenteral Medicines, Inc.
Vinorelbine 50 mg/5ml Intravenous Injection
NDC: 0703-4183
Labeler:
Teva Parenteral Medicines, Inc.
Vinorelbine 10 mg/ml Intravenous Injection
NDC: 25021-204
Labeler:
Sagent Pharmaceutical, Inc.
Vinorelbine 10 mg/ml Intravenous Injection, Solution
NDC: 45963-607
Labeler:
Actavis Pharma, Inc.
Vinorelbine 10 mg/ml Intravenous Injection
NDC: 50742-420
Labeler:
Ingenus Pharmaceuticals, LLC
Vinorelbine 50 mg/5ml Intravenous Injection
NDC: 50742-427
Labeler:
Ingenus Pharmaceuticals, LLC
More Results

Related Brands

Drugs with the same active ingredients